GO
Loading...

Enter multiple symbols separated by commas

Perrigo Co

More

  • NEW YORK, April 24- Teva Pharmaceutical Industries' bid for Mylan NV would create a company controlling nearly 25 percent of the U.S. generics market, including drugs in short supply, according to industry experts and a Reuters review of regulatory filings. It is also pursuing a hostile takeover of drugmaker Perrigo Co Plc. Teva has already looked at the...

  • April 22- Generic drugmaker Teva Pharmaceutical Industries Ltd said it could "promptly" divest some operations to obtain regulatory clearance for its proposed $40 billion takeover of smaller rival Mylan NV. Mylan, which has said a merger with Teva would be bad fit, plans to make a new offer for Perrigo Co Plc in the near term, CNBC reported on Wednesday.

  • April 22- Teva Pharmaceutical Industries Ltd said on Wednesday it could "promptly" divest some operations if necessary to obtain regulatory clearance for its proposed takeover of smaller rival Mylan NV. Meanwhile, Canonsburg, Pennsylvania- based Mylan is pursuing its own $29 billion unsolicited bid for Perrigo Co Plc, which the maker of over-the-counter...

  • April 21- Some of the top investors at Mylan NV, including Paulson& Co, are encouraging its board of directors to consider a takeover proposal from rival Teva Pharmaceutical Industries Inc, according to people familiar with the matter. Teva unveiled an unsolicited $40 billion takeover proposal on Tuesday for the Canonsburg, Pennsylvania- based company.

  • Perrigo rejects $205/share bid from Mylan Tuesday, 21 Apr 2015 | 4:26 PM ET

    April 21- Dublin- based Perrigo Company Plc said its board unanimously rejected a $205 per share offer from generic drugmaker Mylan NV, saying the bid substantially undervalued the company. Perrigo said Mylan's offer did not take into account Perrigo's 2.48 billion euros acquisition of Omega Pharma and new products that are expected to generate about $1...

  • April 21- Perrigo Company PLC is set to reject a $29 billion unsolicited takeover offer from generics drugmaker Mylan NV as soon as this week, according to a source familiar with the matter. Teva said that its offer for Mylan is contingent on the company not completing an acquisition of Perrigo or any alternative transaction. Representatives from Perrigo and...

  • TEL AVIV/ NEW YORK, April 21- Generic drugmaker Teva Pharmaceutical Industries Ltd. on Tuesday proposed buying smaller rival Mylan for $40 billion, saying it was a better deal than Mylan's alternate offer to buy Perrigo Co. Teva said the stock-and-cash offer of $82 a share represented a 48 percent premium to Mylan's stock price on March 10, which it said was the...

  • Mylan last week announced a $29 billion offer to buy Perrigo Co Plc in a move that some analysts suggested was a tactic to help fend off an acquisition by larger rival Teva. Mylan Executive Chairman and former Chief Executive Officer Robert Coury said the Perrigo plans remain on track. "Mylan is fully committed to its stand-alone strategy, including its proposal...

  • Teva considering potential bid for Mylan - Bloomberg Friday, 17 Apr 2015 | 2:37 PM ET

    April 17- Teva Pharmaceuticals Industries is considering a bid for Mylan NV, Bloomberg reported, citing people familiar with the matter. Teva has not made a formal approach, Bloomberg reported. Generic drugmaker Mylan offered to buy Perrigo Co Plc for about $29 billion in cash and stock in early April.

  • Deals this week, the busiest so far this year, were worth $140 billion, lifting year-to-date M&A activity to almost $1 trillion, according to Thomson Reuters data. It worked for Mylan on its offer for Perrigo, BG Group in its takeover by Shell, TNT Express in its $4.3 billion bid from Fedex and Permira Advisers and the Canada Pension Plan Investment Board in its...

  • Top trades to go before Thursday's close Thursday, 9 Apr 2015 | 2:26 PM ET

    The "Halftime Report" traders give their trades for the second half.

  • *M&A speculation boosts Burberry, Mediaset. Burberry was flagged by Goldman Sachs among shares on its "conviction buy" lists for which its sees a bid probability of 30 percent or more. Italian media group Mediaset rose 2.2 percent after Mediobanca tipped it as a bid target for France's Vivendi.

  • M&A, car sales help European shares to new 8-year high Thursday, 9 Apr 2015 | 10:21 AM ET

    *M&A speculation boosts Burberry, Mediaset. Burberry was flagged by Goldman Sachs among shares on its "conviction buy" lists for which its sees a bid probability of 30 percent or more. Italian media group Mediaset rose 2.8 percent after Mediobanca flagged it as a bid target for France's Vivendi.

  • *Mylan jumps after offering to buy Perrigo for about $29 bln. *Alcoa flat in extended trading after results. NEW YORK, April 8- U.S. stocks ended a volatile session with modest gains on Wednesday after minutes from a U.S.

  • *Fed minutes indicate rate hike in 2015, but members differ on month. *Mylan jumps after offering to buy Perrigo for about $29 bln. NEW YORK, April 8- U.S. stocks rose on Wednesday, but trading was volatile following the release of minutes from the U.S.

  • *Mylan jumps after offering to buy Perrigo for about $29 bln. Mylan shares jumped 14.4 percent to $68.15, boosting the Nasdaq and the S&P healthcare sector, on news it offered to buy Perrigo for about $29 billion in cash and stock. Perrigo shares jumped 21.7 percent to $200.50.

  • Perrigo expands with Omega Monday, 30 Mar 2015 | 7:47 AM ET
    Perrigo expands with Omega

    Perrigo is set to close a huge deal for Omega Pharmaceuticals. Perrigo CEO Joseph Papa, discusses the benefits of the deal, and the company's move to Ireland.

  • DUBLIN, Feb 26- Malin, an Irish company set up by a number of former Elan executives to invest in privately held life science assets, said it plans to raise between 275 million and 325 million euros in one of Europe's biggest biotechnology IPOs. Former Elan chief executive Kelly Martin and chairman Bob Ingram, who sold the Irish stock market stalwart to Perrigo for...

  • Early Movers: GNRC, PRGO, AOL, LB, WEN & more Thursday, 6 Nov 2014 | 7:57 AM ET

    Some of the names on the move ahead of the open.

  • Cramer: 3 stocks to watch in September Friday, 29 Aug 2014 | 6:01 PM ET

    We're moving into a time of year that’s been difficult for bulls, historically. However, if the market does sell off, Cramer won't cry.